Safety and effectiveness of adalimumab in a clinical setting that reflects Canadian standard of care for the treatment of rheumatoid arthritis (RA): Results from the CanACT study

Safety and effectiveness of adalimumab in a clinical setting that reflects Canadian standard of care for the treatment of rheumatoid arthritis (RA): Results from the CanACT study

<p>Abstract</p> <p>Background</p> <p>This multicenter, open-label, prospective, single cohort study evaluated the effectiveness and safety of adalimumab in a clinical setting reflecting the Canadian standard of care for the treatment of patients with rheumatoid arthriti...

Full description

Bibliographic Details
Main Authors: Haraoui Boulos, Cividino Alfred, Stewart Jacqueline, Guérette Benoît, Keystone Edward C
Format: Article
Language:English
Published: BMC 2011-11-01
Series:BMC Musculoskeletal Disorders
Online Access:http://www.biomedcentral.com/1471-2474/12/261

Internet

http://www.biomedcentral.com/1471-2474/12/261

Similar Items